Diabetes

Researchers are urging Pharmac to fund an automated treatment for type 1 diabetes, which costs $4000 a year and is better at keeping blood glucose levels under control 

A large study of Aotearoa New Zealand’s shift to tighter control of gestational diabetes finds improved outcomes for newborns

Pharmac's First ethnicity criteria for a Special Authority drug have led to a “fantastic” Māori uptake of new diabetes medications, says National Hauora Coalition clinical director and GP Rawiri McKree Jansen.

There has been a high uptake by Māori and Pacific of new diabetes drugs under Pharmac’s first ethnicity-based funding criteria – a publicity campaign to encourage more uptake is to start soon 

Groups who suffer the highest burden of type 2 diabetes have the lowest level of adherence to effective medication to control it, a University of Otago study has found

When a patient named Wayne called Glen Davies a “useless bastard”, it started a journey that would see the Taupō GP rethink his approach to treating type 2 diabetes

Fakaanga Mapa is breaking through cultural norms to ensure the healthcare needs of the communities he loves are taken care of

A senior Pacific doctor says that the enthusiasm the New Zealand government has shown to combat the COVID-19 pandemic is also needed to fight the current diabetes crisis

Give Pharmac’s budgeting and new approach easing Special Authority restrictions on medicines like new diabetes drugs for Māori and Pasifika time, its Māori chief advisor says

Pharmac has approved funding for two new medicines with substantial health benefits for around 53,000 New Zealanders with type 2 diabetes